Asked on Healicus
Do probiotics do anything for IBS?
Answer published by a reader on . AI-generated from the sources below; general educational information, not medical advice.
Probiotics show a modest, strain-dependent benefit for IBS symptoms, but the evidence is low-certainty and no single strain works reliably for everyone.
A 2023 meta-analysis of 82 randomised trials in over 10,000 adults with IBS found that probiotics as a group reduced global symptoms and abdominal pain compared to placebo, but effects were modest and varied considerably by strain 1Goodoory VC et al., Gastroenterology, 2023 — Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysisMeta-analysis · Gastroenterology 2023Some combinations of probiotics or strains may be beneficial in IBS. However, certainty in the evidence for efficacy by GRADE criteria was low to very low across almost all of our analyses.Open on pubmed.ncbi.nlm.nih.gov ↗. An earlier meta-analysis reached a similar conclusion 2Ford AC et al., Aliment Pharmacol Ther, 2018 — Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndromeMeta-analysis · Aliment Pharmacol Ther 2018Which particular combination, species or strains of probiotics are effective for IBS remains, for the most part, unclear. Rifaximin has modest efficacy in improving symptoms in non-constipated IBS.Open on pubmed.ncbi.nlm.nih.gov ↗.
A few strains have individual RCT support:
- Bifidobacterium infantis 35624 (10⁸ CFU/day) beat placebo for abdominal pain and composite symptoms over 4 weeks in a trial of 362 women — but only at that specific dose, not higher or lower ones
- Heat-inactivated Bifidobacterium bifidum MIMBb75 reduced IBS symptoms versus placebo in a well-designed German multicentre trial 4Andresen V et al., Lancet Gastroenterol Hepatol, 2020 — Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trialRandomised trial · Lancet Gastroenterol Hepatol 2020This study shows that B bifidum HI-MIMBb75 substantially alleviates IBS and its symptoms in a real-life setting. These results indicate that specific beneficial bacterial effects are mediated independently of cell viability. FUNDING: Synformulas.Open on pubmed.ncbi.nlm.nih.gov ↗
- Lactobacillus plantarum 299v has low-certainty signal for global IBS symptoms 1Goodoory VC et al., Gastroenterology, 2023 — Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysisMeta-analysis · Gastroenterology 2023Some combinations of probiotics or strains may be beneficial in IBS. However, certainty in the evidence for efficacy by GRADE criteria was low to very low across almost all of our analyses.Open on pubmed.ncbi.nlm.nih.gov ↗
What probiotics have not been shown to do in IBS: prebiotics like inulin/FOS actually worsened flatulence in people with functional bowel disorders, so those are a different story.
The bottom line: strain choice matters enormously, and "probiotics" as a category is too broad to give a blanket answer.
Sources
In this answer
Have a follow-up, or a question of your own? Every answer cites Cochrane, EU regulators, guideline bodies or trials in leading journals.